Ecommerce search and product discovery leader ranks #10 in the world for retail innovation – recognized for 'pointing shoppers toward what they need' and helping brands create high-impact digital experiences that drive revenue Constructor, the leading AI-powered search and product discovery platform for enterprise ecommerce companies, has been named to Fast Company's “World's Most Innovative […]

(NYSE MKT:TOVX), ROCKVILLE, Md., March 19, 2025 (GLOBE NEWSWIRE) — Theriva(TM) Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that the Company's Management will be attending and presenting at the Cancer Advocacy Group of Louisiana (CAGLA) NeauxCancer 2025

Global health company The Cigna Group (NYSE: CI) today announced the successful completion of the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC). The divestment of these assets streamlines The Cigna Group's portfolio and enables it to drive further innovation to support customers.

Brand's revamped app lets busy diners tap out of cooking and tap into chef-quality meals without kitchen hassle DIG, a fast-casual restaurant serving seasonal, scratch-cooked comfort food, has launched its new spring menu highlighting aromatic herb-infused dishes alongside a revamped mobile app experience. https://mma.prnewswire.com/media/2427903/DIG_Logo.jpg Available beginning March 26 at all locations, the menu showcases DIG's

Syrian American Doctors performed life-saving procedures and training during Ramadan amid healthcare crisis During this month of Ramadan, the Syrian American Medical Society (SAMS) is proud to announce the successful completion of its Medical Mission to Syria, where 16 volunteer doctors provided life-saving procedures, urgent medical care, and vital training to local healthcare professionals during

MINNEAPOLIS, March 19, 2025 (GLOBE NEWSWIRE) — Major depression impacts more than 5 million U.S. adolescents every year, and NIH data shows that 20% of those aged 12 to 16 have had at least one major depressive episode*. The FDA has now cleared the Magstim Horizon 3.0 and Inspire Transcranial Magnetic Stimulation Systems for treating

(NYSE:FOXO), MINNEAPOLIS, MN, March 19, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information and biospecimen sourcing provider serving the biotechnology, clinical research and pharmaceutical research industries. Vector expects to generate $800,000 of revenues

(NASDAQ:ONVO), SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock that will become effective at 5:00 p.m.

(NASDAQ:SCNX), TAMPA, FL, March 19, 2025 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, today announced it has completed a

(NASDAQ:MBRX), HOUSTON, March 19, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it will report its financial results for the year ended December 31, 2024, on Friday afternoon, March 21, 2025.